A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Clinical trial NCT02563106 · COMPLETED

Trial details

NCT number: NCT02563106
Sponsor: Theriva Biologics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Clostridium Infections

Start date: 2015-10-01
Primary completion: 2016-11-01
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.